Literature DB >> 25431264

Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions.

Jian-Hong Zhong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25431264     DOI： 10.1007/s13277-014-2881-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  50 in total

1.  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

Authors: 
Journal:  J Hepatol       Date:  2012-03-20       Impact factor: 25.083

2.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

3.  [Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma].

Authors: 
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2013-02

4.  Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Albert C Y Chan; Kenneth S H Chok; Wai Key Yuen; See Ching Chan; Ronnie T P Poon; Chung Mau Lo; Sheung Tat Fan
Journal:  Arch Surg       Date:  2011-06

5.  Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus.

Authors:  Shoji Kubo; Hiromu Tanaka; Shigekazu Takemura; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Hiroji Shinkawa; Hiroki Sakaguchi; Akihiro Tamori; Daiki Habu; Shuhei Nishiguchi
Journal:  Hepatol Res       Date:  2007-02       Impact factor: 4.288

Review 6.  Hepatitis B virus-related cirrhosis: natural history and treatment.

Authors:  Chia-Ming Chu; Yun-Fan Liaw
Journal:  Semin Liver Dis       Date:  2006-05       Impact factor: 6.115

7.  Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.

Authors:  Grace Lai-Hung Wong; Henry Lik-Yuen Chan; Christy Wing-Hin Mak; Stanley King-Yeung Lee; Zoe Man-Yi Ip; Andrew Ting-Ho Lam; Henry Wing-Hang Iu; Joyce May-Sum Leung; Jennifer Wing-Yan Lai; Angeline Oi-Shan Lo; Hoi-Yun Chan; Vincent Wai-Sun Wong
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

8.  Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.

Authors:  J-Q Dan; Y-J Zhang; J-T Huang; M-S Chen; H-J Gao; Z-W Peng; L Xu; W Y Lau
Journal:  Eur J Surg Oncol       Date:  2013-04-15       Impact factor: 4.424

9.  Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.

Authors:  Xiang-Ming Lao; Guangyu Luo; Liang-Tao Ye; Cheng Luo; Ming Shi; Dian Wang; Rongping Guo; Minshan Chen; Shengping Li; Xiaojun Lin; Yunfei Yuan
Journal:  Liver Int       Date:  2013-02-13       Impact factor: 5.828

10.  The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.

Authors:  Makoto Chuma; Shuhei Hige; Toshiya Kamiyama; Takashi Meguro; Atsushi Nagasaka; Kazuaki Nakanishi; Yoshiya Yamamoto; Mitsuru Nakanishi; Toshihisa Kohara; Takuya Sho; Keiko Yamamoto; Hiromasa Horimoto; Tomoe Kobayashi; Hideki Yokoo; Michiaki Matsushita; Satoru Todo; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2009-06-25       Impact factor: 7.527
View more
  13 in total

1.  Efficacy of combined adjuvant transarterial chemoembolization and antiviral therapy in patients with HBV-related hepatocellular carcinoma after surgery.

Authors:  Song-Lin Ma; Yang Lv; Jing-Hang Jiang
Journal:  Tumour Biol       Date:  2015-09-05

2.  The STORM trial and beyond: narrowing the horizon of adjuvant sorafenib for postoperative hepatocellular carcinoma.

Authors:  Jian-Hong Zhong
Journal:  Tumour Biol       Date:  2015-11

Review 3.  Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.

Authors:  Xiao-Jun Lin; Xiang-Ming Lao; Ming Shi; Sheng-Ping Li
Journal:  Dig Dis Sci       Date:  2016-04-22       Impact factor: 3.199

4.  Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after surgery: A comment for moving forward.

Authors:  Jian-Hong Zhong; Tian Yang; Bang-De Xiang; Le-Qun Li; Liang Ma
Journal:  World J Hepatol       Date:  2016-05-08

5.  Feasibility of combining adjuvant transarterial chemoembolization with nucleos(t)ide analog therapy for patients with HBV-associated hepatocellular carcinoma after hepatectomy.

Authors:  Wen-Feng Gong; Jian-Hong Zhong; Bang-DE Xiang; LE-Qun Li
Journal:  Mol Clin Oncol       Date:  2016-04-22

6.  Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization.

Authors:  Zhong-Guo Zhou; Xing-Rong Zheng; Qian Zhou; Ming Shi; Yao-Jun Zhang; Rong-Ping Guo; Yun-Fei Yuan; Min-Shan Chen; Xiao-Jun Lin; Xiang-Ming Lao; Sheng-Ping Li
Journal:  Chin J Cancer       Date:  2015-05-14

7.  Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.

Authors:  Jian-Hong Zhong; Yang Ke; Shao-Liang Zhu; Lin Wang; Cheng-Piao Luo; Wen-Feng Gong; Xue-Mei You; Liang Ma; Bang-De Xiang; Le-Qun Li
Journal:  Onco Targets Ther       Date:  2016-11-10       Impact factor: 4.147

8.  Comment on "Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis".

Authors:  Han-Yue Mo; Bang-De Xiang; Jian-Hong Zhong; Le-Qun Li; Xue-Mei You
Journal:  Can J Gastroenterol Hepatol       Date:  2016-07-14

9.  Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection.

Authors:  Jian-Lin Chen; Xiao-Jun Lin; Qian Zhou; Ming Shi; Sheng-Ping Li; Xiang-Ming Lao
Journal:  Chin J Cancer       Date:  2016-03-18

10.  Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching.

Authors:  Bao-Hong Yuan; Ru-Hong Li; Wei-Ping Yuan; Bang-De Xiang; Ming-Hua Zheng; Tian Yang; Jian-Hong Zhong; Le-Qun Li
Journal:  Oncotarget       Date:  2017-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.